• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.

作者信息

Waters Valerie

机构信息

Research Institute The Hospital for Sick Children Toronto, Ontario, Canada.

Department of Pediatrics The Hospital for Sick Children Toronto, Ontario, Canada.

出版信息

Am J Respir Crit Care Med. 2021 Dec 1;204(11):1245-1247. doi: 10.1164/rccm.202108-1939ED.

DOI:10.1164/rccm.202108-1939ED
PMID:34543576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8786064/
Abstract
摘要

相似文献

1
Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.向前迈进两步：改善囊性纤维化肺部急性加重的管理
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1245-1247. doi: 10.1164/rccm.202108-1939ED.
2
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药物敏感性试验
Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD006961. doi: 10.1002/14651858.CD006961.pub4.
3
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药敏试验
Cochrane Database Syst Rev. 2020 May 15;5(5):CD006961. doi: 10.1002/14651858.CD006961.pub5.
4
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验用于指导囊性纤维化患者的抗生素治疗
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD009528. doi: 10.1002/14651858.CD009528.pub5.
5
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验用于指导囊性纤维化患者的抗生素治疗
Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD009528. doi: 10.1002/14651858.CD009528.pub4.
6
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验在指导囊性纤维化抗生素治疗中的应用
Cochrane Database Syst Rev. 2015 Mar 5(3):CD009528. doi: 10.1002/14651858.CD009528.pub3.
7
Exacerbations in cystic fibrosis: 3--Management.囊性纤维化的病情加重：3 - 管理
Thorax. 2008 Feb;63(2):180-4. doi: 10.1136/thx.2006.060905.
8
Update on treatment of pulmonary exacerbations in cystic fibrosis.囊性纤维化肺部加重期治疗的最新进展。
Curr Opin Pulm Med. 2006 Nov;12(6):440-4. doi: 10.1097/01.mcp.0000245711.43891.16.
9
Twice vs three times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.每日两次与每日三次使用抗生素治疗囊性纤维化肺部加重期
J Cyst Fibros. 2011 Sep;10(5):383. doi: 10.1016/j.jcf.2011.03.010. Epub 2011 Apr 19.
10
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.吸入性抗生素用于囊性纤维化患者的肺部急性加重期
Cochrane Database Syst Rev. 2012 Dec 12;12:CD008319. doi: 10.1002/14651858.CD008319.pub2.

本文引用的文献

1
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.一项囊性纤维化肺部感染加重治疗中抗菌疗程的随机临床试验。
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC.
2
Antibiotic treatment of common infections: more evidence to support shorter durations.常见感染的抗生素治疗：更多支持缩短疗程的证据。
Curr Opin Infect Dis. 2020 Dec;33(6):433-440. doi: 10.1097/QCO.0000000000000680.
3
Finding the relevance of antimicrobial stewardship for cystic fibrosis.寻找抗菌药物管理策略与囊性纤维化的相关性。
J Cyst Fibros. 2020 Jul;19(4):511-520. doi: 10.1016/j.jcf.2020.02.012. Epub 2020 Feb 29.
4
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
5
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.协调慢性囊性纤维化肺部感染抗菌治疗中的药敏试验和临床反应。
Clin Infect Dis. 2019 Oct 30;69(10):1812-1816. doi: 10.1093/cid/ciz364.
6
Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.肺加重标准化治疗2（STOP2）的研究设计考量：一项比较囊性纤维化患者静脉抗生素治疗时长的试验
Contemp Clin Trials. 2018 Jan;64:35-40. doi: 10.1016/j.cct.2017.11.012. Epub 2017 Nov 21.
7
Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.抗生素疗程和儿童细菌感染静脉转口服途径的切换时机：系统评价和指南。
Lancet Infect Dis. 2016 Aug;16(8):e139-52. doi: 10.1016/S1473-3099(16)30024-X. Epub 2016 Jun 16.
8
Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.慢性嗜麦芽窄食单胞菌感染和恶化对囊性纤维化的影响。
J Cyst Fibros. 2012 Jan;11(1):8-13. doi: 10.1016/j.jcf.2011.07.008. Epub 2011 Aug 16.
9
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.囊性纤维化肺部指南：肺部急性加重的治疗
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3.
10
Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.成人呼吸机相关性肺炎抗生素治疗8天与15天的比较：一项随机试验
JAMA. 2003 Nov 19;290(19):2588-98. doi: 10.1001/jama.290.19.2588.